1 - 13 of 13

Matthew A. Deardorff , MD, PhD

Photo of Matthew A. Deardorff

Dr. Deardorff’s work integrates patient information with genomics and cell biology to diagnosis and understand rare genetic disease.  His research focuses on disorders caused by dysregulation of chromatin or altered translational regulation, specifically, Cornelia de Lange, Coffin-Siris, Skraban-Deardorff and KBG syndromes.


Andrew Degnan, MD, MPhil

Andrew Degnan, MD, MPhil

Dr. Degnan's research and clinical training has focused on the development and application of imaging approaches to advance patient care through accurate diagnosis and improved prognostication.


Sara B. DeMauro, MD, MSCE

Sara B. DeMauro, MD, MSCE

Dr. DeMauro has special expertise in rigorous assessment of early childhood outcomes of high-risk neonates. Her research focuses on improving outcomes of children with bronchopulmonary dysplasia and school-age assessment of functional outcomes in preterm-born children.


Dennis Dlugos, MD, MSCE

Dennis Dlugos

Dr. Dlugos is the director of the Section of Clinical Neurophysiology at Children’s Hospital of Philadelphia. He studies epilepsy genetics, pharmacogenetics, and epilepsy surgery. He is also a core faculty member of the ENGIN Frontier Program.


Yoav Dori, MD, PhD

Yoav Dori

Dr. Dori is a pediatric cardiologist and director of Pediatric Lymphatic Imaging and Interventions and Lymphatic Research.


Steven D. Douglas, MD

Steven D. Douglas

Dr. Douglas has extensive laboratory experience investigating the cellular immunology of HIV/AIDS, primary immune deficiency diseases, and cellular immunopathologies. In addition, he has had significant involvement in studies related to immunological interactions.


Nadia L. Dowshen, MD, MSHP

Nadia L. Dowshen

Dr. Dowshen focuses on improving the health outcomes for adolescent and young adults (AYA) living with or at high risk for contracting HIV/AIDS and improving access and quality of care for gender expansive and transgender children and adolescents. She is particularly interested in developing and testing digital health interventions to reach, engage, and retain AYA in care.